Paris (ots/PRNewswire) - Two studies presented at World Diabetes Congress 2011 provide further evidence of the benefits to patients of early glycemic control on co-morbidities Sanofi announced today new results from sub-analyses of the First Basal INsulin Evaluation in Asia (FINE Asia) Registry study,[1] and the Cardiovascular Risk Evaluation in People with Type 2 ...
London, November 30 (ots/PRNewswire) - Multi-Center Procedure Data Presented in Over 1700 Cases Using the Sensei(R) X Robotic Catheter System Hansen Medical, UK Ltd, a subsidiary of Hansen Medical, Inc., , a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of ...
Bristol-Myers Squibb and AstraZeneca
Paris and London, November 29 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca announced today that the European Commission has granted marketing authorisation for KOMBOGLYZETM (saxagliptin and metformin HCl immediate-release fixed dose combination) that will cover the 27 Member States of the European ...
Melbourne, Australia, November 28 (ots/PRNewswire) - Ansell Limited (ANN.AX), a global leader in protection solutions, today announced it has purchased a minority share of Yulex Corporation, a manufacturer of biopolymers derived from guayule. The investment is not expected to have any material impact on Ansell's earnings per share in Fiscal Years 2012 and 2013. Further, Ansell and Yulex executed an exclusive agreement for ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris, November 25 (ots/PRNewswire) - - REYATAZ(R) is the only boosted PI to include dosing and medical guidance in pregnancy and postpartum in the label - Bristol-Myers Squibb Company today announced that the European Commission approved a labelling update for REYATAZ(R) (atazanavir sulfate) based on new data ...
http://resources.euroadhoc.com/us/BdZOgnI9 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Zutphen, the Netherlands, November 22 (ots/PRNewswire) - This landmark storage of the 200,000th stem cell sample indicates a step forward in Cryo-Save's leading role in the cord blood industry Cryo-Save is proud to announce the storage of its 200,000th sample. This great achievement shows the successful results of ...
GENEVA and PLAN- LES-OUATES, Switzerland, November 21, 2011 (ots/PRNewswire) -- BELOTERO Balance(R) has now been approved by the US Food and Drug Administration (FDA) for injection into the mid-to-deep dermis to correct moderate-to-severe facial wrinkles and folds such as nasolabial folds. BELOTERO Balance(R) is a hyaluronic acid-based cohesive gel dermal filler that ...
London, November 18 (ots/PRNewswire) - AstraZeneca today announced that the Marketing Authorisation Application for CAPRELSA (vandetanib) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of aggressive and symptomatic medullary thyroid cancer (MTC) in ...
Montreal, November 16 (ots/PRNewswire) - Sunshine Biopharma Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has successfully completed the preclinical studies for Adva-27a, the ...
London, November 15 (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply consensus forecasts of global drug sales, announced today the launch of its new clinical trial intelligence service, EP Clinical Trials [http://www.evaluatepharma.com/clinical ][SM]. By linking EudraCT [https://eudract.ema.europa.eu ] and ...
RED BANK, New Jersey, MELBOURNE, Australia, and BRUSSELS, November 15, 2011 (ots/PRNewswire) -- In just 15 years, Ansell's best-selling brand sells 500M pairs worldwide Ansell, global leader in health and safety solutions with over a century of expertise, has today reached a historic milestone - the sale of its 500 millionth pair of HyFlex(R) gloves. Since its creation, the HyFlex [http://www.ansell.com/corporate/ ...
Paris, November 15 (ots/PRNewswire) - CRI's Amigo(TM) system allows remote control of Boston Scientific's leading cardiac ablation catheters Boston Scientific Corporation is beginning to market the CRI Amigo(TM) system, a remote-controlled catheter system, and related accessories in select European countries through ...
Paris, November 9 (ots/PRNewswire) - Now available for endoscopic dilation of the Sphincter of Oddi following sphincterotomy Boston Scientific Corporation's CRE(TM) Wireguided Balloon Dilator is now CE marked for endoscopic dilation of the Sphincter of Oddi following sphincterotomy. The new indication, which supplements the product's current indication for use in the ...
http://resources.euroadhoc.com/us/ToCwLq5B http://resources.euroadhoc.com/us/o1izYpb6 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 ...
SURESNES, France and MONTRÉAL, November 8, 2011 (ots/PRNewswire) - Les Laboratoires Servier, France (Servier) and Prognomix Inc., Canada (Prognomix) announced today that they have entered into a research and development agreement aimed at identifying novel targets as part of programs meant to develop innovative type 2 diabetes and metabolic disease treatment. This ...
DNDi - Drugs for Neglected Diseases initiative
Geneva, Switzerland/New Delhi, India (ots) - A comprehensive four-year project including over 10,000 patients in clinical and pharmacovigilance studies for diagnosis and treatment of visceral leishmaniasis (VL, also known as kala-azar) in India and Bangladesh was launched by an international consortium formed last ...
BRUSSELS, REDBANK, New Jersey and MELBOURNE, Australia, November 4, 2011 (ots/PRNewswire) -- Contact: Media, Wouter Piepers, GCC-Ansell, Tel: (00322) 5287400, wpiepers@eu.ansell.com, US - Jeff Picarello, Edelman PR, Tel:(1212)7048244, jeff.picarello@edelman.com, I.R., David Graham, I.R.-Ansell, Tel:(613)92707215, ...
issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: Open Market / XETRA: Frankfurt, free trade: Berlin, Main Standard: ...
Hilden, Germany, and Gaithersburg, Md. (ots) - Vaginal self-collection for Hybrid Capture®-based HPV testing increases screening coverage and is more sensitive than Pap smear shows a Mexican study published today online in the Lancet Promising findings published today online in the Lancet[i] from a community- based, randomized equivalence trial undertaken by public ...
Geneva, Switzerland (ots) - In an article published today in the European Respiratory Journal, results from a study on electronic cigarettes show users get as much nicotine from this product as smokers usually get from tobacco cigarettes. The study, by researchers from the Universities of Geneva and Auckland, reports levels of cotinine (a product of the degradation of ...
London, November 1 (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply reliable consensus forecasts of global drug sales, revealed today that Sanofi is expected to take the top spot amongst the world's pharmaceuticals manufacturers in 2012 and hold it through 2016. The French drug maker has raced up the rankings over the last decade largely through M&A activity, ...
Plan-les-Ouates, Switzerland (ots) - Viroblock S.A., a company with a highly innovative, broadly applicable anti-viral air filtration technology, initially focused on development and commercialization of anti-viral face-masks, today announced the successful closure of a 3.3 million CHF Series C financing round. Dr Jamie Paterson, CEO of Viroblock, said "these funds allow Viroblock to complete the development of our ...
St. Gallen, Switzerland (ots) - Fora Care Suisse AG located in St. Gallen, Switzerland announced today the launch of its Total and Complete Mobility line of blood glucose monitoring devices and tools. The Total and Complete Mobility line (TCM) which was presented for the first time at the (EASD) in Lisbon, Portugal ...
issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: Open Market / XETRA: Frankfurt, free trade: Berlin, Main Standard: SIX Swiss Exchange language: English ...
Zutphen, Netherlands (ots/PRNewswire) - Cryo-Save, Europe's leading family stem cell bank launches an educational program on stem cell therapies. The aim of the program is to increase the awareness of stem cells therapy and regenerative medicine amongst healthcare professionals. Cryo-Save Serbia played a lead role ...
http://resources.euroadhoc.com/us/HvMAMlXw issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Irvine, California and Amsterdam (ots/PRNewswire) - Agendia, an innovative molecular diagnostics company, today announced that its supervisory board of directors has appointed David Macdonald as chief executive officer. This follows the resignation of the company's co-founder and chief executive officer, Dr. Bernhard Sixt. Dr. Sixt will remain with the company in an advisory capacity. Agendia also announced the addition ...
Burcon NutraScience Corporation
Vancouver (ots/PRNewswire) - Burcon NutraScience Corporation ("Burcon" or the "Company") is pleased to announce that its common shares have been authorized to commence trading on The NASDAQ Global Market under the symbol "BUR" on October 27, 2011. To acknowledge this achievement, Burcon is scheduled to ring The NASDAQ Opening Bell on October 27th, 2011. The NASDAQ Opening Bell Ceremony will take place from 9:15 am to 9:30 ...
Paris (ots/PRNewswire) - - New findings from the pivotal TEMSO Phase III study presented today at the joint ECTRIMS / ACTRIMS Congress - - U.S. FDA Accepts New Drug Application for Teriflunomide for relapsing forms of MS - Sanofi and its subsidiary Genzyme announced today new data from the pivotal TEriflunomide ...